Bayesian vs Frequentist Testing: When to Use Each (From Someone Who Uses Both)
---
Editorial disclosure
This article lives on the canonical GrowthLayer blog path for indexing consistency. Review rules, sourcing rules, and update rules are documented in our editorial policy and methodology.
By Atticus Li -- Applied Experimentation Lead at NRG Energy (Fortune 150). Creator of the PRISM Method. Learn more at atticusli.com
The Bayesian vs frequentist debate in experimentation circles has become almost religious. People pick a side and defend it like their career depends on it.
I use both. At NRG Energy, where we run 100+ experiments per year, the answer to "which statistical framework should I use?" is always "it depends." And after sitting down with Optimizely's internal statistics team for a deep-dive session, I became even more convinced that the right answer is pragmatic, not philosophical.
Here is how I actually decide which approach to use, and when.
The 30-Second Version for People Who Just Want the Answer
Use Bayesian when: you need to make decisions quickly, your sample sizes are small, stakeholders want probability statements ("there is a 94% chance B is better"), or you are running always-on optimization.
Use frequentist when: you need regulatory-grade rigor, you have clear sample size requirements, you want results that are easy to defend in peer review, or you are running high-stakes tests where the cost of a false positive is very high.
Use both when: you are running an enterprise experimentation program and different tests have different requirements. Which is most of the time.
What Bayesian Testing Actually Gives You
Bayesian testing treats your test parameters as probability distributions rather than fixed unknowns. Instead of asking "is the difference statistically significant at p < 0.05?", it asks "what is the probability that variant B is better than variant A, given the data we have observed?"
In practice, this means:
Intuitive probability statements. When I tell a VP "there is a 96% probability that this variant increases conversion rate," they understand that immediately. When I say "we rejected the null hypothesis with p = 0.03," I get blank stares followed by "so... is it better?"
Flexible stopping. Bayesian methods handle peeking at results more gracefully than traditional frequentist approaches. The posterior probability updates continuously. You can check your results daily without inflating your error rate the way you would with a fixed-sample frequentist test. This matters when a test is clearly winning or losing early and you want to reallocate traffic.
Prior information integration. If you have run 50 similar tests and know the typical effect size range, Bayesian methods let you incorporate that knowledge. At NRG, we use weakly informative priors based on historical test results -- not to bias the outcome, but to stabilize estimates when sample sizes are small.
Better handling of small samples. Some of our tests run on niche customer segments where we will never get 50,000 visitors. Bayesian methods give us useful (if uncertain) estimates where frequentist tests would just say "inconclusive."
What Frequentist Testing Actually Gives You
Frequentist testing asks a narrower question: "if there were truly no difference between A and B, how likely is it that we would observe data this extreme?" That p-value, combined with pre-specified sample sizes and significance levels, gives you:
Clear, pre-registered decision rules. Before the test starts, you know exactly how many visitors you need, what significance level you are using, and what minimum detectable effect you are powering for. There is no ambiguity about when to stop or what counts as a result.
Regulatory and scientific defensibility. If your test results need to survive an audit, a legal review, or academic peer review, frequentist methods are the gold standard. The framework has 100 years of theoretical backing and well-understood error rate guarantees.
Protection against false positives at known rates. When you set alpha at 0.05 and power at 0.80, you know your false positive rate and your false negative rate in advance. With Bayesian methods, the equivalent guarantees depend on your prior specification, which introduces subjectivity.
Simplicity for well-powered tests. When you have plenty of traffic and a clear hypothesis, frequentist testing is straightforward. Calculate sample size, run the test, check the result. No prior selection, no posterior interpretation debates.
What I Learned from Optimizely's Statistics Team
I had a session with the statistics team at Optimizely that changed how I think about this. Three things stuck with me.
First, most "Bayesian" implementations in commercial tools are not purely Bayesian. They use Bayesian-inspired methods with specific computational shortcuts. The probability to be best (PTB) that Optimizely reports is a genuine Bayesian quantity, but the way they compute it involves choices about priors and loss functions that most users never examine. This is not a criticism -- it is a reminder to understand what your tool is actually calculating.
Second, sequential testing in the frequentist framework has closed much of the gap. Methods like alpha spending functions and always-valid p-values let you peek at frequentist results without inflating error rates. The practical difference between "Bayesian flexible stopping" and "frequentist sequential testing" is smaller than the marketing materials suggest.
Third, the biggest source of bad test results is not the statistical framework. It is bad instrumentation. Whether you use Bayesian or frequentist methods, if your tracking is broken, your segments are leaking, or your randomization is biased, the math will give you a confident wrong answer. The statistics team's advice: spend more time on AA testing and data quality than on debating frameworks.
That third point resonated deeply. I have seen more tests ruined by broken event tracking than by the wrong statistical method.
My Decision Framework at NRG
Here is exactly how I choose:
High-traffic pages, clear primary metric, regulatory or financial sensitivity: frequentist. We pre-register the hypothesis, calculate the required sample size, and run the test to completion. No peeking, no early stopping. This covers roughly 40% of our experiments.
Optimization tests, multiple variants, need for speed: Bayesian. When we are testing 3-4 hero variants and want to quickly identify and kill losers, Bayesian multi-armed bandit approaches work well. We set a threshold (e.g., 95% probability to be best) and let the algorithm allocate traffic dynamically. This covers roughly 30% of our experiments.
Small-segment tests, personalization experiments, exploratory work: Bayesian with informative priors. When sample sizes are limited and we have historical data, Bayesian methods give us directional insight where frequentist tests would return nothing. About 20% of experiments.
Tests that stakeholders will scrutinize heavily: frequentist, regardless of other factors. When the CMO is going to ask "are you sure?" in a leadership meeting, I want a pre-registered test with a clean p-value and a confidence interval. The extra rigor is worth the extra time. About 10% of experiments overlap into this category.
Sequential Testing and False Discovery Rate
Running 100+ experiments per year means we are going to get false positives. At a 5% significance level, that is 5+ false winners per year -- tests where we ship a change that does not actually help.
We manage this two ways:
Sequential testing with alpha spending. For frequentist tests where we need interim looks (stakeholder pressure, resource allocation decisions), we use O'Brien-Fleming alpha spending boundaries. This lets us check results at pre-specified intervals without inflating the overall false positive rate.
False discovery rate control across the portfolio. We apply Benjamini-Hochberg corrections when evaluating our overall test portfolio. A test that is significant at p = 0.04 in isolation might not survive FDR correction when considered alongside 20 other tests running the same quarter. This is uncomfortable -- nobody likes having a "winner" downgraded -- but it keeps our shipped changes honest.
For Bayesian tests, we use a minimum posterior probability threshold of 95% and require the expected loss (the cost of choosing the wrong variant) to be below a business-meaningful threshold. This serves a similar purpose: reducing the rate of false discoveries across the portfolio.
The Practical Takeaway
Stop asking "Bayesian or frequentist?" Start asking "what does this specific test need?"
If you are running fewer than 10 experiments per year, pick one framework, learn it well, and stick with it. The consistency matters more than the choice.
If you are running 50+, build competence in both. Your pricing page test and your homepage hero test have different requirements. Treating them identically is leaving insight on the table.
And regardless of which framework you use: fix your instrumentation first. Run AA tests. Verify your tracking. The fanciest statistical method in the world cannot fix bad data.
Atticus Li leads enterprise experimentation at NRG Energy, running 150+ total experiments with a 24%+ win rate. Learn more about his experimentation approach at atticusli.com.
Applied Experimentation Lead at NRG Energy (Fortune 150) · Creator of the PRISM Method
Atticus Li leads applied experimentation at NRG Energy (Fortune 150), where he and his team run more than 100 controlled experiments per year on customer-facing surfaces. He is the creator of the PRISM Method, a framework for high-velocity experimentation programs at large enterprises. He writes regularly about the statistical and operational details of A/B testing — the parts most CRO content skips.
Keep exploring
Browse winning A/B tests
Move from theory into real examples and outcomes.
Read deeper CRO guides
Explore related strategy pages on experimentation and optimization.
Find test ideas
Turn the article into a backlog of concrete experiments.
Back to the blog hub
Continue through related editorial content on the main domain.